Literature DB >> 10537262

In vivo measurement of acetabular cement pressurization using a simple new design of cement pressurizer.

A M New1, M D Northmore-Ball, K E Tanner, S K Cheah.   

Abstract

Aseptic loosening of the acetabular component remains a limiting factor in the long-term success of total hip replacement. An instrumented pressurizer has been designed to allow the intraoperative measurement of acetabular cement pressurization, which is known to contribute to implant fixation. Average intraoperative cement pressures in 16 operations performed by 2 surgeons were 49 +/- 17 kPa (6.4 +/- 2.3 psi) and 47 +/- 17 kPa (6.2 +/- 2.2 psi), and peak pressures were 76 +/- 5 kPa (10.0 +/- 0.6 psi) and 93 +/- 15.kPa (12.2 +/- 1.9 psi), comparable to previous work in vitro. The pressurization required for optimal cement penetration into cleaned low-density cancellous bone is reported to be of the order of 35 to 50 kPa (4.6-6.6 psi) for 30 to 60 seconds, and the present data show that this is attainable in vivo using a simple device.

Mesh:

Substances:

Year:  1999        PMID: 10537262     DOI: 10.1016/s0883-5403(99)90037-2

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  3 in total

1.  Modified femoral pressuriser generates a longer lasting high pressure during cement pressurisation.

Authors:  Jian-Sheng Wang; Göran Garellick; Fred Kjellson; Elizabeth Tanner; Gunnar Flivik
Journal:  J Orthop Surg Res       Date:  2011-10-17       Impact factor: 2.359

2.  Anaphylactic shock during cement implantation of a total hip arthroplasty in a patient with underlying mastocytosis: case report of a rare intraoperative complication.

Authors:  Anita Ten Hagen; Pieter Doldersum; Tom van Raaij
Journal:  Patient Saf Surg       Date:  2016-11-05

3.  The addition of a flange does not improve the pressure generated during cemented acetabular cup implantation.

Authors:  Alexander T Boote; David J Deehan; Kenneth S Rankin; David C Swailes; Philip J Hyde
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2022-06-03       Impact factor: 3.405

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.